Associate Director, PET Drug Manufacturing Operations
Jubilant Draxlmage Radiopharmacies Inc, dba Jubilant Radiopharma | |
401(k)
| |
United States | |
Jun 25, 2026 | |
|
Associate Director, PET Drug Manufacturing OperationsLocation: Remote (United States) with travel up to 50% About Jubilant Radiopharmacies At Jubilant Radiopharmacies, we help deliver life-changing diagnostic imaging that supports earlier detection and better patient outcomes. Our team manufactures and distributes PET radiopharmaceuticals used every day in hospitals and clinics across the country. We are committed to safety, quality, and innovation-and to creating an inclusive environment where talented people can grow and make an impact. Why This Role - Why Now at Jubilant RadiopharmaciesJubilant Radiopharmacies is entering a pivotal phase of growth-expanding our PET radiopharmaceutical footprint and investing significantly in next-generation manufacturing capabilities to bring critical diagnostic solutions closer to patients. This is a unique opportunity for a leader in medical isotope manufacturing to shape the future of PET operations at scale. As we grow our network of cyclotron-enabled facilities and advance new radiopharmaceutical products, we are looking for someone who can combine deep technical expertise in isotope production with strong, people-first leadership. In this role, you won't just maintain operations-you will build, scale, and standardize across a rapidly evolving manufacturing network. You'll lead experienced teams, elevate quality culture, and drive operational excellence in an environment where precision, speed, and compliance directly impact patient care. Key Responsibilities
We offer competitive compensation, an annual performance bonus, generous vacation, and 401K matching. Inclusion & Equal OpportunityJubilant Radiopharmacies is proud to be an equal opportunity employer. We are committed to building a diverse and inclusive workforce where all employees feel valued, respected, and empowered to contribute. We welcome applicants from all backgrounds and provide reasonable accommodations to support individuals with disabilities throughout the hiring process. | |
401(k)
Jun 25, 2026